Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Bugatti

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation RequirementsFrances Humby, Stephen Kelly, Serena Bugatti, et al.
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
Rheumatology and Therapy|April 12, 2026
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational StudyCaterina Baldi, Eleonora Celletti, Serena Bugatti, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Adult-onset Still's disease with elderly onset: results from a multicentre studyIlenia Di Cola, Claudia Di Muzio, Alessandro Conforti, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registryAndreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
The Journal of Rheumatology|June 3, 2015
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation RequirementsFrances Humby, Stephen Kelly, Serena Bugatti, et al.
The Journal of Rheumatology|December 16, 2024
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and DiscontinuationMarco Sebastiani, Gemma Lepri, Claudia Iannone, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
Rheumatology and Therapy|April 12, 2026
Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational StudyCaterina Baldi, Eleonora Celletti, Serena Bugatti, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Adult-onset Still's disease with elderly onset: results from a multicentre studyIlenia Di Cola, Claudia Di Muzio, Alessandro Conforti, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Frontiers in Immunology|July 6, 2026
Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registryJurgen Sota, Andrea Hinojosa-Azaola, Eduardo Martín-Nares, et al.
Pageof 10